These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28692819)

  • 1. Physical activity modifies the influence of apolipoprotein E ε4 allele and type 2 diabetes on dementia and cognitive impairment among older Mexican Americans.
    Shih IF; Paul K; Haan M; Yu Y; Ritz B
    Alzheimers Dement; 2018 Jan; 14(1):1-9. PubMed ID: 28692819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.
    Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB
    J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
    Irie F; Fitzpatrick AL; Lopez OL; Kuller LH; Peila R; Newman AB; Launer LJ
    Arch Neurol; 2008 Jan; 65(1):89-93. PubMed ID: 18195144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.
    Irie F; Masaki KH; Petrovitch H; Abbott RD; Ross GW; Taaffe DR; Launer LJ; White LR
    Arch Gen Psychiatry; 2008 Aug; 65(8):906-12. PubMed ID: 18678795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can elderly apolipoprotein E ε4 carriers remain free from dementia?
    Ferrari C; Xu WL; Wang HX; Winblad B; Sorbi S; Qiu C; Fratiglioni L
    Neurobiol Aging; 2013 Jan; 34(1):13-21. PubMed ID: 22503000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
    Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
    JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
    Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
    Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.
    Pendlebury ST; Poole D; Burgess A; Duerden J; Rothwell PM;
    Stroke; 2020 Mar; 51(3):751-758. PubMed ID: 32070224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
    Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
    Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive effects of physical activity and APOE-ε4 on white matter tract diffusivity in healthy elders.
    Smith JC; Lancaster MA; Nielson KA; Woodard JL; Seidenberg M; Durgerian S; Sakaie K; Rao SM
    Neuroimage; 2016 May; 131():102-12. PubMed ID: 26265157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia.
    Luck T; Riedel-Heller SG; Luppa M; Wiese B; Köhler M; Jessen F; Bickel H; Weyerer S; Pentzek M; König HH; Prokein J; Ernst A; Wagner M; Mösch E; Werle J; Fuchs A; Brettschneider C; Scherer M; Maier W
    Psychol Med; 2014 Apr; 44(6):1319-29. PubMed ID: 23883793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect between apolipoprotein E ε4 and diabetes mellitus for dementia: result from a population-based study in urban China.
    Zhao Q; Xiong Y; Ding D; Guo Q; Hong Z
    J Alzheimers Dis; 2012; 32(4):1019-27. PubMed ID: 22890095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.
    Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Kenney AE; Gross CJ; Taub ES; Plassman BL; Fisher GG
    Neuropsychology; 2013 Jan; 27(1):86-94. PubMed ID: 23356599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study.
    Pink A; Stokin GB; Bartley MM; Roberts RO; Sochor O; Machulda MM; Krell-Roesch J; Knopman DS; Acosta JI; Christianson TJ; Pankratz VS; Mielke MM; Petersen RC; Geda YE
    Neurology; 2015 Mar; 84(9):935-43. PubMed ID: 25653291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.